Intracellular Thiol Redox Status Regulates Lymphangiogenesis and Dictates Corneal Limbal Graft Survival by Fukumoto, Akiko et al.
Intracellular Thiol Redox Status
Regulates Lymphangiogenesis and
Dictates Corneal Limbal Graft Survival
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Fukumoto, Akiko, Kazuichi Maruyama, Tony Walsh, Kentaro Kajiya,
Junji Hamuro, Patricia A. D’Amore, and Shigeru Kinoshita. 2010.
“Intracellular Thiol Redox Status Regulates Lymphangiogenesis and
Dictates Corneal Limbal Graft Survival.” Investigative Opthalmology
& Visual Science 51 (5) (May 1): 2450. doi:10.1167/iovs.09-4618.
Published Version 10.1167/iovs.09-4618
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:35013973
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Intracellular Thiol Redox Status Regulates
Lymphangiogenesis and Dictates Corneal
Limbal Graft Survival
Akiko Fukumoto,1 Kazuichi Maruyama,1 Tony Walsh,2 Kentaro Kajiya,4 Junji Hamuro,1
Patricia A. D’Amore,2,3 and Shigeru Kinoshita1
PURPOSE. Compounds regulating intracellular thiol redox status,
such as N,N-diacetyl-L-cystine dimethylester (NM2), were
shown to prolong corneal graft survival in a penetrating kera-
toplasty (PKP) model. However, the effect of NM2 on heman-
giogenesis and lymphangiogenesis has not been investigated.
The effect of manipulating ambient thiol redox status on riskier
(higher rejection rate) transplantation models, such as limbal
graft survival and hemangiogenesis and lymphangiogenesis in a
corneal suture model, were investigated.
METHODS. C57BL/10 mice that received BALB/c corneas were
treated by subconjunctival injection of NM2, and limbal graft
survival was assessed. Sutured C57BL/6 received daily intra-
peritoneal injections of NM2, glutathione diethylester (GSH-
OEt), or PBS. Lymphatic endothelial cell (LEC) and peritoneal
mps were treated with NM2 or GSHOEt, and then VEGFR3,
neuropilin-2, podoplanin, and LYVE-1 expression were ana-
lyzed. Supernatants were collected for analysis of TNF- and
VEGF-A levels by ELISA.
RESULTS. Significantly less cellular infiltration was detected in
mice with corneal limbal transplant–treated NM2-treated mice.
Hemangiogenesis and lymphangiogenesis were suppressed in
the NM2-treated mice. NM2 treatment of mps led to reduced
levels of VEGFR3, neuropilin-2, podoplanin, and LYVE-1 ex-
pression compared with PBS- or GSHOEt- treated mps, lower
levels of TNF-, and increased secretion of VEGF. Moreover,
NM2-treated LECs had reduced levels of LYVE-1 and Prox-1.
CONCLUSIONS. Reduction of ambient redox status reduced inflam-
matory cell infiltrates. Consequently, reduced inflammatory re-
sponse might have contributed to both the observed prolonged
corneal limbal graft survival and the attenuated hemangiogenesis
and lymphangiogenesis in cornea. (Invest Ophthalmol Vis Sci.
2010;51:2450–2458) DOI:10.1167/iovs.09-4618
L ymphangiogenesis is a critical milestone in tumor progres-sion because the extravasation of tumor cells through lym-
phatic vessels is thought to play a role in tumor dissemina-
tion.1,2 The lymphatic system also plays an essential role in the
immune response to infectious agents.3 Afferent lymphatic
vessels are the route through which antigen-presenting cells
(APCs) migrate to the regional lymph nodes and lymphoid
organs.
The cornea is normally devoid of blood and lymphatic
vessels; however, under inflammatory conditions, such as su-
ture placement or corneal transplantation, lymphatic vessels
are induced in the corneal stroma. We have previously sug-
gested that lymphangiogenesis correlates with corneal rejec-
tion reaction after transplantation.4–6 We and others have
suggested that inflammatory cells, including mps, support lym-
phangiogenesis7,8 either by transdifferentiating into lymphatic
endothelial cells (LECs) and directly incorporating into the
lymphatics or by stimulating the division of local LECs.9
With inflammation, such as that induced by lipopolysaccha-
ride, VEGF-C and VEGFR3 expression is induced on peritoneal
CD11b mps.7 Newly recruited bone marrow–derived cells or
mesenteric cells, such as mps,10 are known to produce angio-
genic factors such as VEGF-A, -C, -D and TNF-, thereby playing
a major role in inducing lymphangiogenesis and angiogenesis
in the cornea.10,11
NM2 treatment in corneal transplantation models (penetrat-
ing keratoplasty [PKP]) successfully prolonged graft surviv-
al,12,13 at least in part by reducing the mps production of
proinflammatory mediators such as IL-12 and nitric oxide (NO)
and by inhibiting the ongoing Th1 immune responses. Tissue
stromal inflammatory reactions indirectly influence the cyto-
kine milieu at the sties of inflamed tissue. Glutathione (GSH)
constitutes the first line of the cellular defense against oxida-
tive injury.14 Intracellular GSH (icGSH) in mps is central to
determining the production of IL-12 by regulating MAPK p38
and JNK activities,13–17 indicating that icGSH is critical for
determining whether the Th1 or Th2 response predomi-
nates.15,18 Exposure of mps to IFN- increased the icGSH/
oxidized icGSH (icGSSG) ratio, whereas exposure to IL-4 de-
creased it.13,17 Mps with decreased icGSH are known as
oxidative mps (OMps), and those with increased amounts as
referred to reductive mps (RMps).16–20 The former was phar-
macologically induced by NM2, whereas the latter was phar-
macologically induced by GSHOEt.13,14,16,19,20 RMps/Th1 con-
tributes to tissue damage, followed by inflammatory stromal
reactions. Then OMps, induced under impaired blood flow,
may mediate tissue regeneration.17,19–21 The roles of RMps and
OMps in the induction of lymphangiogenesis and hemangio-
genesis has not been investigated, though the correlation be-
tween ambient hypoxia and angiogenesis has been widely
documented22,23
Corneal limbal transplantation (LT) is performed to recon-
stitute the ocular surfaces of patients lacking corneal epithelial
stem cells because of factors such as chemical burns and
Stevens-Johnson syndrome.24–26 Corneal epithelium stem cells
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are located in the sclerocorneal limbus and function as a source
of healthy corneal epithelial cells.4 In patients with unilateral
and bilateral ocular surface damage, limbal autotransplantation
and allogeneic LT, respectively, provide a means for supplying
healthy corneal epithelial stem cells.27–30 The donor and host
limbus and the subepithelial and stromal layers contain a large
number of APCs (e.g., dendritic cells and mps)31,32 that are
responsible for triggering active immune and inflammatory
responses.33–36 Consequently, LT might be confronted with
the efficient host recognition of the donor graft, followed by
the acute allosensitization and swift rejection. In addition, the
corneal epithelial layer participates in defense against the spon-
taneous invasion of blood and lymphatic vessels,37,38 and abun-
dant lymphatic and blood vessels in the host limbus may
participate in maintaining the inflammatory response.
Our previous paper showed that the Th2-biased immune
system could block the rejection reaction in the PKP mod-
el.12,13 Considering the less immune privileged status in limbus
of cornea, it is easy to imagine that the LT is far more suscep-
tible to immunologic rejection. In this study, we used NM2
treatment to alter intracellular thiol redox status and tested its
effects on cellular infiltration into cornea after LT and whether
it can influence graft survival. The effect of changing thiol
redox status in mps using NM2 treatment both on corneal




Eight-week-old male C57BL/6 mice purchased from Japan CREA (Shi-
zuoka, Japan) were used in the suture placement model. Seven- to
10-week-old male BALB/c and B10.D2 (H-2d) mice were used for the
limbal transplantation model. All animals were treated in accordance
with the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research, and all experiments were approved by the Committee
for Animal Research of Kyoto Prefectural University of Medicine.
Modulation of Ambient Redox Status
NM2 (Bachem, Bubendorf, Switzerland: E-1770) was used to induce
oxidation. Glutathione diethylester (GSH-OEt; Sigma, St. Louis, MO)
was used to stimulate the reductive conditions. Before limbal trans-
plantation, BALB/c and B10.D2 mice were injected subconjunctivally
with 20 g NM2 or GSH-OEt (50 L) using a 30-gauge needle; the
controls received saline containing hyaluronic acid. Hosts received
three pretransplantation injections with either NM2 or saline (days7,
3, 0); donors were treated twice (days 7, 3). Alternatively, trans-
plant recipients received three intraperitoneal injections of 200 g
(500 L); controls were injected with saline only. Transplant donors
were injected intraperitoneally twice. Mice with suture placement
received NM2 injections of 200 g (500 L) and GSH-OEt (2 mg/100
L) intraperitoneally every day after suture placement for 7 days.
Mouse Limbal Transplantation and Suture
Placement in Corneal Stroma
Before limbal transplantation, all animals were deeply anesthetized
with an intraperitoneal injection of 3 to 4 mg ketamine and 0.01 mg
xylazine. Briefly, the cornea without scleral tissue was excised along
the limbus of the donor eye, and the corneal endothelial cell layer was
completely peeled off using two forceps. The corneal epithelium of
deeply anesthetized BALB/c hosts was scraped off completely, the
adjacent limbal and conjunctival tissues were dissected circumferen-
tially, and the donor corneal tissue with the limbus was placed on the
host cornea. Each corneal lenticule was secured around the recipient
corneal limbus with eight interrupted 11-0 nylon sutures (MANI, Inc.,
Tochigi, Japan). Subsequently, a 2  2-mm hole was placed in the
center of the donor cornea, and a cut was made parallel with the host
limbus (Fig. 1). Finally, antibiotic ointment was applied to the corneal
surface, and the eyelids were sealed for 72 hours with 8-0 nylon
tarsorrhaphy (Alcon Surgical, Dallas, TX). Cases that were technically
difficult (limbal perforation, anterior chamber hemorrhage during or
after surgery, suture loosening, lenticule separation, cataract during
the observation period) were excluded from further study. Using
stromal incisions that encompassed 120° of the corneal circumfer-
ence, three 11-0 nylon sutures were placed intrastromally. To obtain a
standardized angiogenic response, the outer edge of the suture was
placed halfway between the limbus and the line outlined by the 2-mm
trephine; the inner edge was equidistant from the 2-mm trephine.
Sutures were left in place for 7 days.
Evaluation and Scoring of Limbal Transplantation
After 72 hours the eyelids were opened, and the grafts were evaluated
daily under a slit lamp biomicroscope. Corneal reepithelialization was
evaluated at 4, 7, and 14 days using 0.25% methylene blue staining. At
each time point, the grafts were scored for opacification using the
method previously described,26 where 0 represents clear cornea; 1
represents lenticular and regional corneal epithelial edema, opacity, or
clearly visible iris vessels; 2 represents diffuse epithelial edema, corneal
opacity, or both, and obscuring of the iris vessels; 3 represents diffuse
epithelial edema, corneal opacity, or both, and absence of iris vessel
visualization; and 4 represents invisibility of the anterior chamber
because of epithelial edema, corneal opacity, or both. Regardless of
their opacity score at 4 weeks, grafts with opacity scores of 2 or higher
were considered rejected (immunologic failure) because some grafts
were only transiently opacified. Some mice with an opacification grade
FIGURE 1. Limbal transplantation model. Cornea, without scleral tis-
sue, was excised along the limbus of the donor eye. The donor corneal
endothelial cell layer was then peeled off, and both adjacent limbal and
conjunctival tissues were dissected circumferentially. Whole corneal
tissue with limbus was grafted onto the host cornea and was secured
to the recipient corneal limbus with 8-interrupted 11-0 nylon sutures.
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of 2 were euthanatized by cervical dislocation, and their enucleated
eyes were examined histologically. The eyes of mice scored as grade 2
contained numerous infiltrating cells with prominent central edema
and disarrayed basal corneal epithelium.
Determination of Hemangiogenesis
and Lymphangiogenesis
Mice were euthanatized on day 7 after transplantation. The corneas
were excised, rinsed three times in PBS, and fixed in acetone for 1
hour. They were then rinsed once again in PBS, blocked with 2%
BSA-PBS, and incubated overnight at 4°C with rabbit anti–mouse
LYVE-1 antibody (1:200; Reliatech, Braunschweig , Germany).39,40 The
tissues were then washed, blocked, and stained overnight with rat
anti–mouse CD31 (PECAM-1; 1:100; BD PharMingen), then finally
washed, blocked, and stained with FITC- and Cy3-conjugated second-
ary antibody (1:100; Jackson ImmunoResearch Laboratories, West
Grove, PA). Double-stained whole-mount sections were analyzed un-
der a fluorescence microscope (Olympus, Tokyo, Japan) and an in-
verted and upright confocal laser-scanning microscope (TSC-SP2;
Leica, Wetzlar, Germany). Digital pictures of the flat-mounts were
taken with an image analysis system (Spot, Chantilly, VA), and the area
covered by blood and lymphatic vessels positive for CD31/LYVE-139,40
was measured using ImageJ software (developed by Wayne Rasband,
National Institutes of Health, Bethesda, MD; available at http://rsb.
info.nih.gov/ij/index.html). The total corneal area covered by these
vessels was outlined using the innermost vessel of the limbal arcade as
FIGURE 2. Effect of NM2 treatment
on histology and survival of corneal
transplants. (a) Control mice typi-
cally reject corneas at day 7. (b) At
day 7, the epithelia of the control
group appear defective. (c, d) By day
14, the corneas of the controls be-
came opacified and exhibited a
rough surface. (e, f) In contrast, the
corneas of NM2-treated mice were
clear on day 7. (g, h) At day 14, the
NM2-treated corneas remained clear
and displayed smooth surfaces. (k)
Methylene blue stain revealed reepi-
thelialization. (i, k) The epithelia of
the donor lenticule of untreated mice
contained many infiltrating cells. (j,
l) In contrast, the epithelia of NM2-
treated mice showed few invading
lymphocytes, and the epithelial cells
were aligned in central areas of the
cornea. (m) Survival rate after trans-
plantation with or without NM2. NM2
treatment promoted long-term graft
survival of minor H disparate donor
allograft. B10.D2 corneal allografts
were grafted after treatment of NM2
(n  14 F), or control (n  7 f).
Results are presented as Kaplan-
Meier survival curves.
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the border; the area of blood and lymphatic neovascularization within
the cornea was calculated and normalized to the total corneal area
(expressed as a percentage of the cornea covered by vessels).
Collection and Culture of mps from the
Peritoneal Cavity
Thioglycollate-induced mps were collected from the peritoneal cavity
(peritoneal exudates cells [PECs]) of healthy 8-week-old male C57BL/6
mice.41 PECs were washed, resuspended, and cultured (24 hours at
37°C in 5% CO2 and air; 10
6 cell/plate) in 35-mm culture plates in RPMI
1640 medium containing 10% BSA (Sigma), 1  105 M 2-mercapto-
ethanol (Sigma), 10 mM HEPES, 0.1 mM nonessential amino acid, 1 mM
sodium pyruvate, 100 U/mL penicillin, and 100 g/mL streptomycin
(BioWhittaker, Walkersville, MD).
RT-PCR, Western Blot Analysis, and ELISA
For RT-PCR analysis, total RNA was extracted from PECs or LECs
(STAT-60; Life Technologies, Rockville, MD). First-strand cDNA was
prepared from total RNA by reverse transcriptase using oligo (dT)
primers. VEGF-C, VEGFR3, neuropilin (NRP)-2, and VEGFR1 expres-
sion were detected with primers by RT-PCR.10 Podoplanin protein
expression was detected by Western blot analysis using rabbit anti–
mouse podoplanin (kindly gifted by Dontscho Kerjaschki, Vienna,
Austria). TNF- and VEGF-A were measured with ELISA.
FIGURE 3. Effect of NM2 treatment
on hemangiogenesis and lymphangio-
genesis after corneal transplantation.
(a) Wholemount cornea stained with
the pan-endothelial cell marker CD31
(green). (b) Angiogenesis was sup-
pressed in NM2-treated mice com-
pared with PBS-treated mice (*P 
0.0111). (c) Whole-mount cornea
stain with the lymphatic endothelial
cell marker LYVE-1 (red). (d) Lym-
phangiogenesis was significantly sup-
pressed in the NM2-treated mice
compared with the GSH-OEt–treated
mice (**P  0.0019) and the PBS-
treated mice (*P  0.0027).
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Real-Time PCR Analysis
Total RNA was reverse transcribed (TaqMan Mutiscribe RT Kit; Applied
Biosystems, Foster City, CA), and amplification was performed (ABI
7300 Real Time PCR System; Applied Biosystems). The following
primers and probes were designed (PrimerExpress software; Ap-
plied Biosystems): Prox-1 forward 5-CTTCCGCCATCCCTTTCC-3,
reverse 5-GGGAGCACCTAGTGGACTCTGA-3, and FAM-TGCCCTT-
GATGGCTTATCCAT-BHQ; LYVE-1 forward 5-CAGCAGCAGCGC-
CTACTTG-3, reverse, 5-CCGGGTGGTGGCAGAA-3, and FAM-
TCATCCCCTGACTCCACAACACC-TAMRA.
Relative expression levels of the target gene mRNAs were calcu-
lated by the comparative CT method. All target sequences were nor-
malized to 18S mRNA (VIC-labeled TaqMan reagents; Applied Biosys-
tems) in multiplexed reactions performed in duplicate. Differences in
CT values were calculated for each target mRNA after subtracting the
mean value of 18S rRNA (relative expression  2DCT).
Statistical Analysis
Kaplan-Meier survival curves and the Breslow-Gehan-Wilcoxon test
were used to compare allograft survival. The Mann-Whitney U test was
used to assess statistical significant for the neovascularization score
(NV) score, and Student’s t-test was used for the proliferation response.
P  0.05 was considered significant.
RESULTS
Effect of NM2on the Fate of the Limbal Transplant
Each control host (n  7) rejected the corneal limbal graft
within 5 days. In contrast, when both donors and recipients
(n  7 each) were treated with NM2 before transplantation,
the cornea remained clear until the end of the 21-day observa-
tion period (80% acceptance, P  0.001; Fig. 2m). Reepitheli-
alization of the donor corneal epithelium proceeded from the
limbus to the central cornea; the entire corneal surface was
reepithelialized within 3 to 4 days after transplantation. Host
reepithelialization occurred as reported previously.26 In most
control mice, the epithelium became progressively opacified,
and the corneal surface ceased to be smooth (Figs. 2a–d). In
NM2-treated mice, the corneal surface exhibited no opacity on
the fifth day after transplantation, and it was completely clear
FIGURE 4. Effect of NM2 treatment
on the PEC morphology and expres-
sion of lymphatic-specific markers.
(a) Morphology of PEC after NM2
stimulation. (b) RT-PCR of VEGFR3,
neuropilin-2, VEGFR1, VEGF-C mRNA
expression. (c) Quantification of
VEGFR3, neuropilin-2, and VEGF-C
expression by RT-PCR. (d) Western
blot analysis of podoplanin expres-
sion.
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and smooth until day 14 (Figs. 2e–h). Three NM2-treated and
control mice were killed on day 7, and their eyes were exam-
ined histologically. The central areas and the subepithelia of
the corneas of control mice contained numerous infiltrating
cells (Figs. 2i, 2k). In contrast, the epithelium of NM2-treated
recipient mice contained few invading inflammatory cells and
the epithelium was normally aligned in the central areas of the
cornea (Figs. 2j, 2l).
Effect of NM2 Treatment on Blood and Lymphatic
Vessel Growth in Corneal Suture Model
At day 7 after suture placement, blood and lymphatic vessel
growth in PBS-treated mouse corneas, quantified by the area of
CD31, blood, and LYVE-1 lymphatic vessels 7 days after
suture placement, was equivalent to those of PBS-treated mice.
Lymphangiogenesis was significantly suppressed in the NM2-
treated mice compared with GSH-OEt-treated mice (P 
0.0019) and PBS-treated control mice (P  0.0027; Fig. 3).
Angiogenesis was suppressed in NM2-treated mice compared
with PBS-treated mice (P  0.0111; Fig. 3).
Effect of NM2 on Macrophage Production of
Angiogenesis-Related Factors
NM2-treated PECs became spindle-shaped after 24 hours of
culture (Fig. 4a) and led to a reduction in the expression of
VEGFR3 (vs. PBS, P  0.0290; vs. GSH-OEt, P  0.0074),
neuropilin-2 (vs. PBS, P  0.0072; vs. GSH-OEt, P  0.03,694)
(Figs. 4b, 4c). Moreover, VEGFR1 expression was significantly
reduced in NM2-treated PECs (Fig. 4b). The downregulation of
podoplanin compared with PBS or GSH-OEt–treated PECs was
confirmed by Western blot analysis (Fig. 4d). These results
suggest that an oxidative milieu leads to reduced expression of
lymphatic markers on mps.
The expression of VEGF-C, the ligand for VEGFR3 known to
be a stimulator of lymphatic vessel growth, was not changed in
NM2-treated peritoneal mps compared with PBS- or GSH-OEt–
treated mps (Figs. 4b, 4c). The level of VEGF-A released by
NM2-treated mps was significantly higher than from GSH-OEt–
treated mps (P  0.0328; Fig. 5a). In contrast, higher levels of
TNF- secretion were detected from GSH-OEt–treated than
from NM2-treated mps (P  0.0254; Fig. 5b).
Effect of NM2 on the Expression of Lymphatic-
Related Factors by LEC
NM2-treated LECs became polygonal after 24 hours (Fig. 6a)
and expressed reduced levels of Prox- and LYVE-1 (Figs. 6b,
6c), indicating that an ambient oxidative milieu leads to the
suppression of lymphatic-related markers on LECs.
DISCUSSION
Corneal inflammation is associated with corneal limbal trans-
plantation and suture placement. We have shown that corneal
FIGURE 5. Cytokine secretion by
NM2-stimulated PECs. VEGF-A and
TNF- levels, measured by ELISA, in
supernatants of PECs 24 hours after
stimulation with NM2. (a) VEGF-A se-
cretion from NM2-treated PECs was
significantly higher than that from
GSH-OEt–pulsed mps (*P  0.0328).
Levels of TNF- released by GSH-OEt–
pulsed PECs were higher than in NM2-
treated PECs (*P  0.0254) (b).
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inflammation, characterized by cell infiltration, hemangiogen-
esis, and lymphangiogenesis, were attenuated by pharmacolog-
ically skewing ambient thiol redox status to an oxidative status
with NM2. The observed in vitro effects of NM2 on mps pro-
duction of hemangiogenesis- and lymphangiogenesis-related
proteins led us to speculate that the ambient redox status
resulted in an aggravated inflammatory response that might
have contributed to impaired graft survival in patients who
underwent corneal limbal transplantation.
Lymphatic and blood vessel growth are both integral in
wound healing and tissue remodeling.42–44 The role of mps, as
a source of diverse mediators and as phagocytes during wound
healing, has been well documented.45 Mps recruited to in-
flamed sites regulates tissue repair and induces the formation
of lymphatic and blood vessels.3,4,11 We and others10–12 have
previously shown that monocytes/mps participate in the for-
mation of lymphatic vessels during inflammation.10–12 Mps
depletion with clodronate improved graft survival in a PKP
model,46 demonstrating the central role of mps in pathologic
corneal inflammation.
We have previously shown that peritoneal monocytes/mps
express markers of lymphatic endothelium, including LYVE-1,
podoplanin, and Prox-1, and that mps contribute to the forma-
tion of lymphatic vessels during acute inflammation in the
cornea.7,8,47 We also demonstrated that peritoneal mps form
lymphatic vessel-like tubes in vitro in a density-dependent
manner.7 These observations, together with our current find-
ings, lead us to postulate that the reduction in inflammatory
infiltrates in corneal stroma of NM2-treated mice may be the
cause of the attenuated lymphatic and blood vessel formation
in the suture model.
Mps that reside in the limbal areas of both donor and host
corneas may be involved in transplant rejection. In the pene-
trating keratoplasty model, APCs of recipients, especially mps,
played a predominant role in antigen recognition.48 NM2 treat-
ment of only donor or recipient corneas did not result in
improved graft survival in this LT model; both donor and
recipient corneas had to be treated to achieve improved graft
survival. We speculate that the rejection reaction depended, at
least in part, on the number of APCs in this LT model. This
FIGURE 6. Morphology and the ex-
pression of lymphatic- specific mark-
ers on LEC. Top: photomicrograph of
LEC after NM2 stimulation. Bottom:
real-time RT-PCR analysis of Prox-1
(*P  0.033, **P  0.015) and
LYVE-1 (*P  0.05, **P  0.015) ex-
pression.
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hypothesis is supported by our finding that only pretreatment
of both donors and recipients with NM2, which induced anti-
inflammatory APCs, led to suppression of the graft rejection.
Previously, we reported that the Th2-biased immune system
could suppress not only the rejection reaction but also neovas-
cularization in an LT model.49 As discussed, manipulating
icGSH by NM2 should have a critical role in determining
whether the Th1 or the Th2 response predominates. Inducing
the Th2-type response by NM2 treatment would result in less
inflammation in this LT model.
The induction of hemangiogenesis and lymphangiogenesis
may depend in part on the infiltration of inflamed cells, such as
mps, into the corneal stroma after scraping of the epithelium
layer or after suture placement. It would be difficult to deter-
mine whether hemangiogenesis and lymphangiogenesis could
also have been induced by rejection reaction and to what
extent that might have contributed to the observed findings.
The simple corneal neovascularization model might be more
useful for future study. The oxidative condition might have
suppressed hemangiogenesis and lymphangiogenesis in this
suture placement model.
Our observation of VEGF-A and VEGF-C expression by bone
marrow–derived mps in the inflamed corneal stroma10 indicate
that they are a likely source of these factors during inflamma-
tion, when they may function to induce blood and lymphatic
vessel formation.50 Therefore, we felt it was relevant to try to
determine whether NM2-treated mps were functionally distinct
from GSH-OE–treated mps, which would have an elevated
icGSH. NM2-treated mps exhibited significantly reduced ex-
pression of VEGFR3, NRP-2, VEGFR-1, and podoplanin com-
pared with GSH-OE–treated mps. Further, the NM2-treated mps
expressed elevated VEGF-A and reduced TNF- levels in com-
parison with GSH-OEt–treated mps. We speculate that mps
under oxidative conditions (such as induced by IL-4)13,19–21 or
reductive conditions (such induced by IFN-)13,14,16,19–21 stim-
ulate lymphatic or blood vessel growth by producing angio-
genic, lymphangiogenic, or antiangiogenic factors. To date
there has been no functional categorization of mps in terms of
their effect on lymphangiogenesis. One report51 suggests that
IFN-–activated mps are not angiogenic, whereas IL-4–stimu-
lated mps secrete proangiogenic factors. Despite the elevated
secretion of VEGF-A, NM2-treated mps might not have been
affected because of their reduced expression of VEGFR-1.
Detailed study will be needed to clarify the contrasting effect of
NM2, namely the upregulation of VEGF-A and the downregu-
lation of VEGFR-1.
It has been proposed that changes in mps function because
of altered icGSH play a role in the pathologic progression of
inflammation. It has been reported that NM2 or GSH-OEt ad-
ministration in mice with autoimmune diabetes results in the
inhibition or elevation, respectively, of the Th1-type cytokine
milieu.19 Our previous studies showed that the suppression of
Th1 polarization, followed by skewing to Th2 dominance,
prolonged graft survival in a limbal transplantation model.49
However, in this model, the cornea grafted to the host with
suppressed Th1, skewed Th2 responses elicited few infiltrating
cells in contrast to the control cornea, and the recipient did not
acquire donor graft-specific tolerance.49 The redox status of
mps, as measured by icGSH, varies with disease progression in
autoimmune mice.19,20 At the time of tissue injury, mps skew
to reductive mps with elevated icGSH levels, whereas tissue
remodeling is associated with oxidative mps with decreased
icGSH levels.
The paradigm that the sequential conversion redox status of
mps (or other inflammatory cells) dictates the pathologic pro-
gression of tissue inflammation and wound healing is consis-
tent with the results observed in this study. We hypothesize
that NM2
- primed inflammatory cells, including oxidative mps,
suppress the Th1-type immune-inflammatory axis. Our data
clearly showed that the in vivo administration of NM2 induced
oxidative mps,12 and histologic analysis revealed a lesser de-
gree of inflammatory cell invasion in the NM2 treatment group
than in the controls. These findings point to a therapeutic role
for NM2 in the suppression not only of corneal stromal inflam-
mation but of hemangiogenesis and lymphangiogenesis in the
cornea.
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